Nutraceuticals comprise foods, or extracts from foods, that supposedly confer medicinal benefits. Nutraceuticals have become popular with the veterinary community; worldwide estimates of sales approach $100 billion. Such economic success has, for the most part, not been accompanied by scientific evidence of efficacy. As with herbs, a broad and continually expanding spectrum of nutraceuticals exists, but the mechanisms of action, indications, contraindications, adverse effects, and evidential support vary with the product and species. It is beyond the scope of this brief summary to discuss specific nutraceutical products.
One type of nutraceutical in particular warrants mention. “Glandulars,” “tissue extracts,” or other scientific-sounding equivalent names purportedly improve the health of animals in which the same glands or tissues have become dysfunctional. Although these products are not FDA approved for veterinary usage, veterinary glandulars and related supplements are heavily promoted in the lay veterinary medicine literature. Their usage began in the USA during the late 19th century when the practice arose of giving fresh thyroid glands to patients as treatment for hypothyroidism. Subsequently, tissues and extracts from other organs (ovary, adrenal, testis, thymus, brain, etc) became popular treatments. Once standardized medications and hormonal replacements became available, medical practitioners largely ceased prescribing glandular derivatives because medication offered more reliable effects without the unpredictable hormonal effects of extracts and concentrates. The use of raw bovine pancreas in some dogs with exocrine pancreatic insufficiency is a notable exception. Of specific concern with spinal cord and brain "glandulars" is the potential for these CNS derivatives to transmit spongiform encephalopathy.
Last full review/revision August 2013 by Narda G. Robinson, DO, DVM, MS